title: pH-sensitive liposomes--principle and application in cancer therapy.
abstract: The purpose of this review is to provide an insight into the different aspects of pH-sensitive liposomes. The review consists of 6 parts: the first introduces different types of medications made in liposomal drug delivery to overcome several drawbacks; the second elaborates the development of pH-sensitive liposomes; the third explains diverse mechanisms associated with the endocytosis and the cytosolic delivery of the drugs through pH-sensitive liposomes; the fourth describes the role and importance of pH-sensitive lipid dioleoylphosphatidylethanolamine (DOPE) and research carried on it; the fifth explains successful strategies used so far using the mechanism of pH sensitivity for fusogenic activity; the final part is a compilation of research that has played a significant role in emphasizing the success of pH-sensitive liposomes as an efficient drug delivery system in the treatment of malignant tumours. pH-Sensitive liposomes have been extensively studied in recent years as an amicable alternative to conventional liposomes in effectively targeting and accumulating anti-cancer drugs in tumours. This research suggests that pH-sensitive liposomes are more efficient in delivering anti-cancer drugs than conventional and long-circulating liposomes due to their fusogenic property. Research focused on the clinical and therapeutic side of pH-sensitive liposomes would enable their commercial utility in cancer treatment.
authors: New Drug Delivery Systems Laboratory, Pharmacy Department, Donors' Plaza, Opp. University Main Office, M S University of Baroda, Vadodara-390 002, India.
authors: H
authors: H
authors: Karanth
authors: R S R
authors: RS
authors: Murthy
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D003600:Cytosol; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D016503:Drug Delivery Systems; D015195:Drug Design; D004705:Endocytosis; D006863:Hydrogen-Ion Concentration; D008081:Liposomes; D008561:Membrane Fusion; D009369:Neoplasms / Q000188:drug therapy*; D010714:Phosphatidylethanolamines
chemical_list: D000970:Antineoplastic Agents; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D008081:Liposomes; D010714:Phosphatidylethanolamines; C094877:dioleoyl phosphatidylethanolamine